InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

Current share price for DXB : $0.230 0.005 (2.13%)+

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$138 Application for quotation of securities - DXB 17 Jul 2024 10:41AM $0.500 $0.230 fallen by 54%
$138 Dimerix presentation at Bioshares Biotech Summit 12 Jul 2024 8:25AM $0.450 $0.230 fallen by 48.89%
$138 Adolescent Recruitment into ACTION3 Clinical Trial 4 Jul 2024 8:55AM n/a $0.230 n/a
$138 Application for quotation of securities - DXB 3 Jul 2024 11:38AM n/a $0.230 n/a
$138 Application for quotation of securities - DXB 26 Jun 2024 3:20PM $0.530 $0.230 fallen by 56.60%
$138 Application for quotation of securities - DXB 21 Jun 2024 9:05AM $0.585 $0.230 fallen by 60.68%
$138 Application for quotation of securities - DXB 13 Jun 2024 2:13PM $0.590 $0.230 fallen by 61.02%
$138 Dimerix to present at Melbourne Twilight Investor Briefing 13 Jun 2024 8:40AM $0.605 $0.230 fallen by 61.98%
$138 Application for quotation of securities - DXB 5 Jun 2024 11:48AM $0.490 $0.230 fallen by 53.06%
$138 Update - Notification of cessation of securities - DXB 3 Jun 2024 2:46PM $0.510 $0.230 fallen by 54.90%
$138 Appendices 3Y and Late Lodgement Notice 3 Jun 2024 2:31PM $0.510 $0.230 fallen by 54.90%
$138 Application for quotation of securities - DXB 31 May 2024 8:26AM $0.455 $0.230 fallen by 49.45%
$138 Investor Presentation 27 May 2024 9:32AM $0.340 $0.230 fallen by 32.35%
$138 Dimerix and Taiba enter into License Agreement for DMX-200 27 May 2024 8:31AM $0.340 $0.230 fallen by 32.35%
$138 Notification regarding unquoted securities - DXB 9 May 2024 8:22AM $0.335 $0.230 fallen by 31.34%
$138 Notification regarding unquoted securities - DXB 7 May 2024 4:11PM $0.345 $0.230 fallen by 33.33%
$138 Proposed issue of securities - DXB 2 May 2024 9:44AM $0.320 $0.230 fallen by 28.13%
$138 Dimerix Receives PIP Approval from the UK MHRA 1 May 2024 8:36AM $0.335 $0.230 fallen by 31.34%
$138 Application for quotation of securities - DXB 30 Apr 2024 10:00AM $0.340 $0.230 fallen by 32.35%
$138 Application for quotation of securities - DXB 22 Apr 2024 11:21AM $0.315 $0.230 fallen by 26.98%
$138 Quarterly Appendix 4C and Activities Report 22 Apr 2024 8:45AM $0.290 $0.230 fallen by 20.69%
$138 Notification of cessation of securities - DXB 12 Apr 2024 10:26AM $0.300 $0.230 fallen by 23.33%
$138 Application for quotation of securities - DXB 10 Apr 2024 10:37AM $0.295 $0.230 fallen by 22.03%
$138 Change of Director's Interest Notice - SP 8 Apr 2024 1:28PM $0.290 $0.230 fallen by 20.69%
$138 Notification of cessation of securities - DXB 5 Apr 2024 8:59AM $0.285 $0.230 fallen by 19.30%

176 - 200 of 738 results

Page 8 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.